COMMUNIQUÉS West-GlobeNewswire
-
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
03/02/2026 -
BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026
03/02/2026 -
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/02/2026 -
Telix Full Year Results 2025 Investor Webcast Notification
03/02/2026 -
Byonyks X1: Revolutionizing Dialysis - Now FDA Cleared and Planning to start Patients in the U.S.
03/02/2026 -
Socrates Health Solutions Announces Advances in Proprietary Non-Invasive Glucose Monitoring Technology; Shareholders Include NFL Players Association and OneTeam Partners
03/02/2026 -
Novo Nordisk releases 2026 sales and operating profit outlook
03/02/2026 -
Novo Nordisk's sales increased by 6% in Danish kroner and by 10% at constant exchange rates to DKK 309.1 billion in 2025
03/02/2026 -
MediGlow Utility (MGU) Releases a Technical Exploration Framework for Digital Identity and Privacy Protection
03/02/2026 -
RESTEM Announces First Patient Dosed in the Phase 2/3 IIMPACT Study of Restem-L in Idiopathic Inflammatory Myopathy
03/02/2026 -
Neomorph Announces First Patient Dosed in Phase 1/2 Trial Evaluating NEO-811 For the Treatment of Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
03/02/2026 -
Berry Street Named to 2026 New York Digital Health 100 List
03/02/2026 -
Excellent Achievements for Clearmind’s Proprietary MEAI that was Included in U.S. Congress’ Emerging Therapies Bill to Expand Veteran Access to Innovative Treatments
03/02/2026 -
Adam Ferrari Announces 2026 Health Science Scholarship to Support Students Dedicated to Caring for Patients with Physical Disabilities
03/02/2026 -
Cynet Named a Strong Performer in 2026 Gartner Peer Insights™ “Voice of the Customer” for Endpoint Protection Platforms
03/02/2026 -
AdhereHealth Announces Appointment of CEO Kempton Presley and President & COO Patrick McNulty as Members of the Board of Directors
03/02/2026 -
Mapi Pharma to Present New Safety and Efficacy Data from Glatiramer Acetate Depot Long-Acting Injection Phase II Study in Patients with Primary Progressive Multiple Sclerosis (PPMS) at ACTRIMS Forum 2026
03/02/2026 -
HFMA’s Vitalic Health to gather more than 50 payers, providers and tech leaders to address rising claim denials
03/02/2026 -
Department of Education Proposal Still Excludes Nursing from “Professional Degree” Definition
03/02/2026
Pages